Observing coronary microvascular disease in patients
China Coronary Microvascular Disease(CCMD) Registry
Henan Institute of Cardiovascular Epidemiology · NCT06676137
This study looks at patients with coronary microvascular disease to see how the condition develops and affects their quality of life and heart health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | Henan Institute of Cardiovascular Epidemiology (other) |
| Locations | 1 site (Zhengzhou) |
| Trial ID | NCT06676137 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients diagnosed with coronary microvascular disease (CMD), a type of non-obstructive coronary heart disease characterized by angina pectoris without significant narrowing of the epicardial vessels. The study aims to prospectively collect data on these patients to observe the disease's development and outcomes, while also exploring the mechanisms behind its occurrence. By gathering clinical evidence, the study seeks to enhance understanding of CMD and its impact on patient quality of life and cardiovascular risks.
Who should consider this trial
Good fit: Ideal candidates for this study are adults experiencing angina symptoms with objective evidence of myocardial ischemia and normal coronary angiography.
Not a fit: Patients under 18 years old or those with non-cardiogenic chest pain or other specific heart conditions will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of coronary microvascular disease, potentially enhancing patient outcomes.
How similar studies have performed: While the study addresses a growing concern in cardiovascular health, similar observational studies have shown varying degrees of success in understanding CMD, indicating both potential and the need for further exploration.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Angina symptoms 2. Objective evidence of myocardial ischemia 3. Coronary angiography was normal,irregular tube wall, or stenosis \<50% Exclusion Criteria: 1. People under the age of 18 2. Non-cardiogenic chest pain and other heart conditions such as variant angina, cardiomyopathy, myocarditis or valvular heart disease
Where this trial is running
Zhengzhou
- Fuwai central China cardiovascular hospotial — Zhengzhou, China (RECRUITING)
Study contacts
- Study coordinator: Quan Guo
- Email: xinyiguoquan@163.com
- Phone: +8615670510031
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Coronary Microvascular Disease